Episode Details
Back to EpisodesThe Emory University science lab behind what could be a gamechanging COVID-19 pill.
Published 4 years, 10 months ago
Description
Drug company Merck is awaiting word on its emergency use-authorization application for its recently announced drug molnupiravir. If approved, the anti-viral drug developed at a lab at Emory University could become the first-ever pill to treat COVID-19. The latest Georgia Today podcast examines the journey that led to this potential breakthrough and its connection to Emory.